Maximus Announces First-Ever Topical Oxytocin Cream for Mood Enhancement and Sleep Support
Santa Monica, CA, Nov. 07, 2025 (GLOBE NEWSWIRE) — Maximus, a leading performance medicine company backed by Founders Fund and 8VC, today announced the launch of Oxytocin Calming Cream, the first topical oxytocin formulation to achieve sustained release through innovative transdermal delivery technology. The patent-pending product solves a long-standing challenge in hormone delivery: maintaining therapeutic […]